BioSyent Inc.
RX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.47% | 18.18% | 11.99% | 7.27% | 10.83% |
| Total Depreciation and Amortization | 48.83% | 153.64% | 106.64% | 108.91% | 85.38% |
| Total Amortization of Deferred Charges | -51.79% | -68.56% | -34.12% | -74.26% | -76.90% |
| Total Other Non-Cash Items | 151.08% | 130.26% | 127.90% | 119.02% | 76.93% |
| Change in Net Operating Assets | -189.58% | -1,456.38% | 165.43% | -488.12% | 160.62% |
| Cash from Operations | 3.26% | 19.19% | 359.72% | -3.42% | 67.72% |
| Capital Expenditure | -17.65% | 49.59% | 12.80% | 23.21% | 45.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.60% | 65.44% | -152.40% | 1,272.79% | 241.28% |
| Cash from Investing | 22.65% | 70.67% | -154.10% | 1,623.66% | 260.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.37% | -5.92% | -5.44% | -5.45% | -5.29% |
| Issuance of Common Stock | -60.38% | 68.54% | 164.25% | 361.73% | 274.29% |
| Repurchase of Common Stock | 82.49% | -71.49% | -42.09% | -14.40% | -55.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.16% | -5.02% | -5.34% | -5.07% | -7.10% |
| Other Financing Activities | 16.72% | 15.91% | 15.16% | 14.48% | 13.45% |
| Cash from Financing | 57.34% | -37.00% | -21.27% | -4.56% | -32.38% |
| Foreign Exchange rate Adjustments | -351.35% | 116.79% | 96.32% | 106.68% | 115.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.99% | 22.96% | -11.90% | 480.67% | 2,577.84% |